Gynecology An estrogen replacement system for managing vasomotor Sx of menopause, Sx of vulval/vaginal atrophy, and treat hypoestrogenism due to hypogonadism, castration, or primary ovarian failure. See Hormone replacement therapy.
References in periodicals archive ?
Transdermal patches include Alora, Climara, Esclim, Estraderm and Vivelle.
Pelletier, Women First vice president -- pharmaceuticals, "We believe in the benefits of Esclim, which have made it the fastest growing estrogen patch in the marketplace.
Calesa, chairman and CEO of Women First, "Women First is in the enviable position of having two flagship brands, Esclim and Vaniqa.
The success of our relatively small sales force in creating demand for Esclim is the focus of analysis for future activity.
In addition to using the latest technology, Esclim offers women the lowest dose in the market (.
Esclim relieves symptoms attributed to blood vessel dilation, such as hot flashes and night-sweats, caused by estrogen loss after removal of the ovaries.
NASDAQ: WFHC) today announced that its transdermal estrogen patch, Esclim (estradiol transdermal system), was added by Medco Health Solutions to its Preferred Drug List effective April 1, 2003.
Further, we are downsizing our Women's Health Division and narrowing our focus to those territories which can profitably detail Esclim and Vaniqa to the OB/GYN community.
Ortho-Est Tablets and Esclim are indicated for the relief of moderate to severe vasomotor symptoms associated with menopause.
Esclim new prescriptions for the 14 weeks after the halting of the combination hormone replacement therapy phase of the Women's Health Initiative trial in early July 2002 were 38% greater than during the 14 weeks leading up to the halting of the trial.